For pancreatic cancer, after analyzing plasma IL6/IL8 levels in patients receiving chemoimmunotherapy, improved disease outcome was showed by treatment-induced IL6/IL8 decrease (37). This evidence concerns the gene CXCL8 and pancreatic neoplasm.